|
ZNF283 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.52591306046679E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.4432899320127E-15 |
| Normal-vs-Stage2 |
3.78050000193753E-08 |
| Normal-vs-Stage3 |
7.65831842386433E-13 |
| Normal-vs-Stage4 |
5.77093928200156E-13 |
| Stage1-vs-Stage2 |
4.112400E-01 |
| Stage1-vs-Stage3 |
1.221390E-01 |
| Stage1-vs-Stage4 |
4.298200E-02 |
| Stage2-vs-Stage3 |
4.790100E-02 |
| Stage2-vs-Stage4 |
2.168000E-02 |
| Stage3-vs-Stage4 |
6.061400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.33639996238821E-09 |
| Normal-vs-Asian |
3.49559999834881E-08 |
| Caucasian-vs-AfricanAmerican |
6.683600E-01 |
| Caucasian-vs-Asian |
2.308200E-01 |
| AfricanAmerican-vs-Asian |
1.990350E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.78590475741203E-11 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
9.524400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62703184258817E-12 |
| Normal-vs-Age(41-60Yrs) |
5.55111512312578E-16 |
| Normal-vs-Age(61-80Yrs) |
2.14639417350782E-12 |
| Normal-vs-Age(81-100Yrs) |
4.001500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.782800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.310600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.338200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.131000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.715200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.498000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.751900E-02 |
| Classical-VS-Follicular |
1.636010E-01 |
| Classical-VS-Other |
1.483160E-01 |
| Classical-VS-Normal |
4.33959979062593E-10 |
| Tall-VS-Follicular |
3.228000E-01 |
| Tall-VS-Other |
7.532400E-01 |
| Tall-VS-Normal |
2.66989763630932E-11 |
| Follicular-VS-Other |
4.993400E-01 |
| Follicular-VS-Normal |
3.12190273632496E-11 |
| Other-VS-Normal |
3.208900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.99200722162641E-16 |
| Normal-vs-N1 |
4.02788913334007E-13 |
| N0-vs-N1 |
7.158200E-02 |
|
|
